L851-1326 Screening compound: 5-{5-cyclohexanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}-3-(2-fluorophenyl)-1,2,4-oxadiazole

L851-1326 Screening compound: 5-{5-cyclohexanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}-3-(2-fluorophenyl)-1,2,4-oxadiazole
L851-1326 Screening compound: 5-{5-cyclohexanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}-3-(2-fluorophenyl)-1,2,4-oxadiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound L851-1326
5-{5-cyclohexanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}-3-(2-fluorophenyl)-1,2,4-oxadiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L851-1326

Molecular Formula

C22H24FN5O2 (C22 H24 FN5 O2)

Compound Name

5-{5-cyclohexanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}-3-(2-fluorophenyl)-1,2,4-oxadiazole

IUPAC name

5-{5-cyclohexanecarbonyl-1-methyl-1H4H5H6H7H-pyrazolo[43-c]pyridin-3-yl}-3-(2-fluorophenyl)-124-oxadiazole

SMILES

Cn(c(CC1)c2CN1C(C1CCCCC1)=O)nc2-c1nc(-c(cccc2)c2F)no1

InChI

InChI=1S/C22H24FN5O2/c1-27-18-11-12-28(22(29)14-7-3-2-4-8-14)13-16(18)19(25-27)21-24-20(26-30-21)15-9-5-6-10-17(15)23/h5-6,9-10,14H,2-4,7-8,11-13H2,1H3

InChI Key

TWDQIPNDCCQDDE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27480301

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

409.46

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.443

Distribution Coefficient, logD

3.443

Water Solubility, LogSw

-3.84

Polar Surface Area

63.164

Acid Dissociation Constant (pKa)

22.50

Base Dissociation Constant (pKb)

0.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.50

L851-1326 in Drug Discovery

Included in Screening Libraries

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • Proteases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L851-1326 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L851-1326?
Check Price and Availability of L851-1326, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L851-1326 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L851-1326
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L851-1326
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L851-1326 available by request